Cas:30221-43-3 3,7,11-trimethyldodecan-5-ol manufacturer & supplier

Chemical Name:3,7,11-trimethyldodecan-5-ol

CAS.NO:30221-43-3

Synonyms:3,7,11-trimethyl-dodecan-5-ol;3,7,11-TRIMETHYL-5-DODECANOL;5-Dodecanol,3,7,11-trimethyl

Molecular Formula:C₁₅H₃₂O

Molecular Weight:228.41400

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:20.23000

Exact Mass:228.24500

LogP:4.63600

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3,7,11-trimethyl-dodecan-5-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Dodecanol,3,7,11-trimethyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,7,11-trimethyl-dodecan-5-ol Use and application,3,7,11-TRIMETHYL-5-DODECANOL technical grade,usp/ep/jp grade.

Related News: Biogen’s top research chief, Dr. Al Sandrock, defended the drug in an open letter released alongside the company’s earnings Thursday, saying its approval has been subject to “extensive misinformation and misunderstanding.” 4-hydroxy-2-oxo-1-propoxy-N-(2-sulfamoylphenyl)-1,2-dihydroquinoline-3-carboxamide manufacturers The vaccine has been through the ringer over safety worries before. In April, U.S. authorities halted its use and later tagged it with a warning over reports of rare blood clots occurring alongside bleeding in some recipients. 1-methylene-4a-methoxycarbonyl-1,2,3,4,4a,5,6,7-octahydronaphthalene suppliers Exploring biocatalysis options at the start of a project is a pragmatic operational strategy to achieve the right product, at the right quality, with exceptional efficiency. 1,5-bis(bis((1-methyl-1H-imidazol-4-yl)methyl)amino)pentan-3-ol hexahydrochloride vendor & factory The CDC’s delay likely came as a disappointment to representatives for the immunocompromised community, who pleaded with the CDC’s expert group to give the go-ahead for booster use in these people, who do not mount a strong enough defense against the virus.,The vaccine has been through the ringer over safety worries before. In April, U.S. authorities halted its use and later tagged it with a warning over reports of rare blood clots occurring alongside bleeding in some recipients.